Zhitong Finance App News, Peger Biopharmaceutical-B (02565.HK) issued an announcement. Since the company and KPMG (KPMG) failed to reach a consensus on the audit fees for the year ended December 31, 2026, the company proposed to dismiss KPMG as the company's auditor for the year ended December 31, 2026 and appoint Rong Cheng (Hong Kong) Certified Public Accountants Limited (Rong Cheng Hong Kong) as the company's new auditor for the year ended December 31, 2026 to fill the temporary period arising after the proposed dismissal Vacant and will hold office until the end of the next annual general meeting of shareholders of the company. It is recommended that the change of auditors be implemented only after (including) the Extraordinary General Meeting of Shareholders to be convened by the company passes the relevant resolution.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.